Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin.
Dong C et al.
Proceedings of the National Academy of Sciences of the United States of America, 2020
Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.
Ashford AL et al.
Cellular and Molecular Life Sciences : Cmls, 2016
A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
Ashford AL et al.
The Biochemical Journal, 2014
Select a paper to view details